Cut-and-Paste Transferrable Pressure Sensing Cartridge Films

Flexible tactile sensors have been intensively studied for healthcare and electronic skin devices. Currently, a sensing material, electrode, and substrate are manufactured as one set by depositing the sensing material on the electrode. For this reason, when another electrode or substrate is used in the sensor or when different sensor characteristics are required, a new sensing material must be developed and the fabrication conditions should be changed. This study proposes a novel method of manufacturing a pressure sensing material like a cartridge film. The cartridge film is made by filling the holes of a stencil film (one MP in each hole) with conductive microparticles (MPs). Using the cartridge film, the sensing material can be cut-and-pasted on electrodes and transferred to other electrodes for reuse. This study analyzes the electrical responses of the sensors made of the cartridge film on the basis of the Hertzian contact theory, and also correlates the sensing performance of the sensors with the conductivity of the MPs and the degree of protrusion of the MPs from the stencil surface.11Nsciescopu

COVID-19 spike polypeptide vaccine reduces the pathogenesis and viral infection in a mouse model of SARS-CoV-2

The SARS-CoV-2 coronavirus, which causes a respiratory disease called COVID-19, has been declared a pandemic by the World Health Organization (WHO) and is still ongoing. Vaccination is the most important strategy to end the pandemic. Several vaccines have been approved, as evidenced by the ongoing global pandemic, but the pandemic is far from over and no fully effective vaccine is yet available. One of the most critical steps in vaccine development is the selection of appropriate antigens and their proper introduction into the immune system. Therefore, in this study, we developed and evaluated two proposed vaccines composed of single and multiple SARS-CoV-2 polypeptides derived from the spike protein, namely, vaccine A and vaccine B, respectively. The polypeptides were validated by the sera of COVID-19-vaccinated individuals and/or naturally infected COVID-19 patients to shortlist the starting pool of antigens followed by in vivo vaccination to hACE2 transgenic mice. The spike multiple polypeptide vaccine (vaccine B) was more potent to reduce the pathogenesis of organs, resulting in higher protection against the SARS-CoV-2 infection.Y